ALX Oncology Holdings, Inc. (ALXO)
1.31
-0.04
(-3.32%)
USD |
NASDAQ |
Sep 25, 16:00
1.40
+0.09
(+6.87%)
After-Hours: 19:59
ALX Oncology Holdings Market Cap : 181.06M for Sept. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 25, 2026 | 181.06M |
| September 24, 2026 | 187.28M |
| September 23, 2026 | 203.18M |
| September 22, 2026 | 221.15M |
| September 21, 2026 | 229.44M |
| September 18, 2026 | 234.97M |
| September 17, 2026 | 240.50M |
| September 16, 2026 | 243.26M |
| September 15, 2026 | 261.23M |
| September 14, 2026 | 266.07M |
| September 11, 2026 | 268.14M |
| September 10, 2026 | 262.61M |
| September 09, 2026 | 254.32M |
| September 08, 2026 | 276.43M |
| September 04, 2026 | 277.81M |
| September 03, 2026 | 280.58M |
| September 02, 2026 | 287.49M |
| September 01, 2026 | 273.67M |
| August 31, 2026 | 266.76M |
| August 28, 2026 | 276.43M |
| August 27, 2026 | 283.34M |
| August 26, 2026 | 273.67M |
| August 25, 2026 | 276.43M |
| August 24, 2026 | 275.05M |
| August 21, 2026 | 281.96M |
| Date | Value |
|---|---|
| August 20, 2026 | 275.05M |
| August 19, 2026 | 284.73M |
| August 18, 2026 | 287.49M |
| August 17, 2026 | 272.29M |
| August 14, 2026 | 270.90M |
| August 13, 2026 | 268.14M |
| August 12, 2026 | 277.81M |
| August 11, 2026 | 266.76M |
| August 10, 2026 | 284.73M |
| August 07, 2026 | 290.25M |
| August 06, 2026 | 291.64M |
| August 05, 2026 | 265.38M |
| August 04, 2026 | 272.29M |
| August 03, 2026 | 259.66M |
| July 31, 2026 | 261.01M |
| July 30, 2026 | 262.35M |
| July 29, 2026 | 261.68M |
| July 28, 2026 | 267.74M |
| July 27, 2026 | 271.77M |
| July 24, 2026 | 273.12M |
| July 23, 2026 | 271.77M |
| July 22, 2026 | 271.77M |
| July 21, 2026 | 275.81M |
| July 20, 2026 | 258.32M |
| July 17, 2026 | 282.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.304B |
| Oncolytics Biotech, Inc. | 85.16M |
| Sangamo Therapeutics, Inc. | 59.66M |
| Sarepta Therapeutics, Inc. | 1.972B |
| Anixa Biosciences, Inc. | 96.14M |
Market Cap Related Metrics
| Price to Book Value | 1.330 |
| Price | 1.31 |
| Earnings Yield | -86.88% |